Based on the results summarized above, we predicted that to suppress hyperlipidemia, Rb1 modulates gut microbiota to increase the level of phosphatidylcholine in glycerophospholipid metabolism, decreasing TC. The gene discussed is RB1; the disease is hyperlipidemia.